NCT07079215 Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms
| NCT ID | NCT07079215 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nu Eyne Co., Ltd. |
| Condition | Opioid Withdrawal (Disorder) |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-05-30 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2025-05-30 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the safety and efficacy of a physical device for medical use (ADTPM 1) applied to opioid withdrawal symptoms.
Eligibility Criteria
Inclusion Criteria: 1. Participants aged 19 to 80 years 2. Participants currently dependent on opioids, whether prescribed or non-prescribed 3. Participants who meet the criteria for opioid use disorder (OUD) according to DSM-5 4. Participants with a Clinical Opiate Withdrawal Scale (COWS) score of 5 or higher 5. Participants with a Numeric Rating Scale (NRS) pain score of less than 6 6. Participants who have voluntarily decided to participate in the study and have provided written informed consent 7. Participants who are willing to comply with the study protocol Exclusion Criteria: 1. Participants with any current uncontrolled or clinically significant medical condition 2. Participants with a history of seizures or epilepsy 3. Participants with a history of neurological disorders or traumatic brain injury 4. Participants who have used long-acting opioids, such as methadone or buprenorphine, continuously for more than 5 days prior to screening 5. Participants who have used methadone wi
Frequently Asked Questions
Who can join the NCT07079215 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 80 Years, studying Opioid Withdrawal (Disorder). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07079215 currently recruiting?
Yes, NCT07079215 is actively recruiting participants. Visit ClinicalTrials.gov or contact Nu Eyne Co., Ltd. to inquire about joining.
Where is the NCT07079215 trial being conducted?
This trial is being conducted at Daegu, South Korea.
Who is sponsoring the NCT07079215 clinical trial?
NCT07079215 is sponsored by Nu Eyne Co., Ltd.. The trial plans to enroll 24 participants.